Performance of functionality measures and phase angle in women exposed to chemotherapy for early breast cancer
- PMID: 33745563
- DOI: 10.1016/j.clnesp.2021.02.007
Performance of functionality measures and phase angle in women exposed to chemotherapy for early breast cancer
Abstract
Purpose: The study aimed to analyze the influence of chemotherapy on nutritional status and the phase angle (PhA) as nutritional indicator for breast cancer women undergoing chemotherapy.
Methods: A prospective study was performed. Women who were starting chemotherapy with no previous chemotherapy treatment were recruited. Quality of life (QoL) was collected using the EORTC QLQ-BR23 questionnaire. Bioelectrical impedance analysis, performance tests, and blood sample to albumin analyzes were collected at 2-time points: diagnosis (T0) and after 1 month of completion of therapy (T1). Mean, standard deviation, linear regression, and ANOVA in R were used to explore the results.
Results: 61 women were included. We did not find any changes in body composition. However, PhA, nutritional risk index (NRI), gait speed (GS), and handgrip strength (HGS) had expressive changes (p < 0.001). 75.4% of women had PhA values below the cut-off point of 5.6°, and the group that had a lower average of PhA also expressed low NRI. PhA was a nutritional status marker and its values were influenced by changes in NRI (p < 0.05).
Conclusion: We have found supporting evidence for chemotherapy treatment resulting in worsening of prognostic factors such as PhA, and yet PhA was related to no nutritional risk. Besides a higher prevalence of obesity, 80% of the sample showed some nutritional risk level, implying the possibility of a sub-notification candidate who might benefit, for instance, from nutritional intervention in obesity groups. Further investigation about this theme may improve health measures for the prevention and screening of disease among breast cancer.
Keywords: Body composition; Early breast cancer; Fatigue; Phase angle; Quality of life.
Copyright © 2021 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no conflict of interest.
Similar articles
-
Phase angle is related to oxidative stress and antioxidant biomarkers in breast cancer patients undergoing chemotherapy.PLoS One. 2023 Jun 8;18(6):e0283235. doi: 10.1371/journal.pone.0283235. eCollection 2023. PLoS One. 2023. PMID: 37289671 Free PMC article.
-
Metabolic syndrome and unfavorable outcomes on body composition and in visceral adiposities indexes among early breast cancer women post-chemotherapy.Clin Nutr ESPEN. 2021 Aug;44:306-315. doi: 10.1016/j.clnesp.2021.06.001. Epub 2021 Jun 9. Clin Nutr ESPEN. 2021. PMID: 34330483
-
Phase angle as a severity indicator for liver diseases.Nutrition. 2020 Feb;70:110607. doi: 10.1016/j.nut.2019.110607. Epub 2019 Oct 11. Nutrition. 2020. PMID: 31743810
-
Routine cancer treatments and their impact on physical function, symptoms of cancer-related fatigue, anxiety, and depression.Support Care Cancer. 2022 May;30(5):3733-3744. doi: 10.1007/s00520-021-06787-5. Epub 2022 Jan 11. Support Care Cancer. 2022. PMID: 35018519 Free PMC article. Review.
-
Bioelectrical Phase Angle in Patients with Breast Cancer: A Systematic Review.Cancers (Basel). 2022 Apr 15;14(8):2002. doi: 10.3390/cancers14082002. Cancers (Basel). 2022. PMID: 35454908 Free PMC article. Review.
Cited by
-
Sedentary Behavior and Phase Angle: An Objective Assessment in Physically Active and Inactive Older Adults.Nutrients. 2023 Dec 27;16(1):101. doi: 10.3390/nu16010101. Nutrients. 2023. PMID: 38201931 Free PMC article.
-
Phase angle is related to oxidative stress and antioxidant biomarkers in breast cancer patients undergoing chemotherapy.PLoS One. 2023 Jun 8;18(6):e0283235. doi: 10.1371/journal.pone.0283235. eCollection 2023. PLoS One. 2023. PMID: 37289671 Free PMC article.
-
Diagnostic and prognostic utility of phase angle in patients with cancer.Rev Endocr Metab Disord. 2023 Jun;24(3):479-489. doi: 10.1007/s11154-022-09776-z. Epub 2022 Dec 9. Rev Endocr Metab Disord. 2023. PMID: 36484944 Review.
-
Phase angle and cellular health: inflammation and oxidative damage.Rev Endocr Metab Disord. 2023 Jun;24(3):543-562. doi: 10.1007/s11154-022-09775-0. Epub 2022 Dec 7. Rev Endocr Metab Disord. 2023. PMID: 36474107 Free PMC article. Review.
-
Prevalence of Sarcopenia in Women with Breast Cancer.Nutrients. 2022 Apr 28;14(9):1839. doi: 10.3390/nu14091839. Nutrients. 2022. PMID: 35565806 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
